Study to Determine the Response and Effectiveness of RSD1235 in Subjects With Atrial Fibrillation or Atrial Flutter

NCT00115791 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

276

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Flutter
Atrial Fibrillation

Interventions

DRUG: RSD1235
DRUG: placebo

Sponsor

Astellas Pharma Inc

Collaborators

[object Object]